Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Clavel

Showing results (91-100 of 155) with videos related to

Pageof 16
Sort By:
European Journal of Cancer & Clinical Oncology|July 1, 1986
Phase II trial of a combination of low dose cisplatin (DDP) and bolus 5-fluorouracil (FU) in recurrent and metastatic squamous cell carcinoma of the head and neckF Cognetti, M Clerico, J Vermorken, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1988
Phase II study of iproplatin (CHIP, JM-9) in advanced testicular cancers progressing after prior chemotherapyM Clavel, S Monfardini, S Gundersen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Phase II study of 5'-deoxy-5-fluorouridine (doxifluridine) in advanced malignant melanomaP Alberto, M Rozencweig, M Clavel, et al.
Investigational New Drugs|July 1, 1989
A phase II study of spirogermanium in patients with advanced malignant lymphomaC Sessa, W ten Bokkel Huinik, M Clavel, et al.
Molecular Pharmaceutics|July 10, 2015
Antiangiogenic and Anticancer Properties of Bifunctional Ruthenium(II)-p-Cymene Complexes: Influence of Pendant Perfluorous ChainsPatrycja Nowak-Sliwinska, Catherine M Clavel, Emilia Păunescu, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1985
cis-Platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC Gastrointestinal Tract Cancer Cooperative GroupA J Lacave, J Wils, E Diaz-Rubio, et al.
Strahlentherapie|December 1, 1974
[Radiotherapy of chronic myeloid leukemia]L Revol, M Cordat, D Rouhier, et al.
Revue Des Maladies Respiratoires|April 11, 2000
[Is risperidone responsible for respiratory manifestations?]F Touraine, M Clavel, E Gericot-Pean, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1989
Phase II study of 9-hydroxy-2-methyl-ellipticinium acetate (ellipticinium) in patients with advanced carcinoma of the lung. EORTC Lung Cancer Cooperative GroupG Anderson, M Clavel, J Smyth, et al.
Neurocirugia (Asturias, Spain)|January 5, 2002
[Posterior lumbar intersomatic fusion]M Clavel-Escribano, A Robles-Balibrea, P Clavel-Laria, et al.
Pageof 16

Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
European Journal of Cancer & Clinical Oncology|July 1, 1986
Phase II trial of a combination of low dose cisplatin (DDP) and bolus 5-fluorouracil (FU) in recurrent and metastatic squamous cell carcinoma of the head and neckF Cognetti, M Clerico, J Vermorken, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1988
Phase II study of iproplatin (CHIP, JM-9) in advanced testicular cancers progressing after prior chemotherapyM Clavel, S Monfardini, S Gundersen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Phase II study of 5'-deoxy-5-fluorouridine (doxifluridine) in advanced malignant melanomaP Alberto, M Rozencweig, M Clavel, et al.
Investigational New Drugs|July 1, 1989
A phase II study of spirogermanium in patients with advanced malignant lymphomaC Sessa, W ten Bokkel Huinik, M Clavel, et al.
Molecular Pharmaceutics|July 10, 2015
Antiangiogenic and Anticancer Properties of Bifunctional Ruthenium(II)-p-Cymene Complexes: Influence of Pendant Perfluorous ChainsPatrycja Nowak-Sliwinska, Catherine M Clavel, Emilia Păunescu, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1985
cis-Platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC Gastrointestinal Tract Cancer Cooperative GroupA J Lacave, J Wils, E Diaz-Rubio, et al.
Strahlentherapie|December 1, 1974
[Radiotherapy of chronic myeloid leukemia]L Revol, M Cordat, D Rouhier, et al.
Revue Des Maladies Respiratoires|April 11, 2000
[Is risperidone responsible for respiratory manifestations?]F Touraine, M Clavel, E Gericot-Pean, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1989
Phase II study of 9-hydroxy-2-methyl-ellipticinium acetate (ellipticinium) in patients with advanced carcinoma of the lung. EORTC Lung Cancer Cooperative GroupG Anderson, M Clavel, J Smyth, et al.
Neurocirugia (Asturias, Spain)|January 5, 2002
[Posterior lumbar intersomatic fusion]M Clavel-Escribano, A Robles-Balibrea, P Clavel-Laria, et al.
Pageof 16